Archives:
Welcome to the 2022 Pipeline Report. Our annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
You can now read the 2022 Pipeline Report updates online, via easily downloadable PDFs, and we’ll be adding more in the coming months. Please feel free to use and share this resource widely in your scientific, policy, and advocacy work.
HCV
Long-Acting Technologies Trials Tracker for Hep C, Opioid Use and Overdose Prevention Therapy, and Malaria
By Joelle Dountio Ofimboudem
July 2022
July 2022